Baxter International opens first Asian biologics plant in Singapore
Published on Aug 7, 2014 2:17 PM
Global healthcare company Baxter International opened its first biologics facility in Asia on Thursday.
It also announced plans for a new processing suite, which will be its second here.
The company said in a statement that this "strengthens Baxter's leadership in hemophilia (a bleeding disorder) and underscores its commitment to increasing access to therapy and improving standards of care for hemophilia patients globally".
The facility and new suite are expected to create 450 biopharmaceutical jobs by next year.
To continue reading, log in if you are a subscriber
Enjoy 2 weeks of unlimited digital access to The Straits Times. Get your free access now!